SGLT2 inhibitors may help reduce the risk of nephrolithiasis in patients with type 2 diabetes, including those with co-existing gout. Recent large-scale studies support that sodium-glucose ...
New research, led by experts at the University of Nottingham, has found that certain types of medication used to treat ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback